Sergio Visentin

Dr. Sergio Visentin

National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2005 in Glia
Verified
Journal Article
Closed access
PDF file
CAC. Agresti
C. Agresti
MMM.E. Meomartini
M.E. Meomartini
SAsusanna amadio
susanna amadio
EAElena Ambrosini
Elena Ambrosini
Barbara SerafiniBarbara Serafini
Barbara Serafini
SVSergio Visentin
Sergio Visentin

1 April 2005 in Brain Research Reviews
Verified
Journal Article
Closed access
CAC. Agresti
C. Agresti
MMM.E. Meomartini
M.E. Meomartini
SAsusanna amadio
susanna amadio
EAElena Ambrosini
Elena Ambrosini
Cinzia VolontéCinzia Volonté
Cinzia Volonté
SVSergio Visentin
Sergio Visentin

1 May 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
RSRoberta De De Simone
Roberta De De Simone
FVFederica Vissicchio
Federica Vissicchio
CMCecilia Mingarelli
Cecilia Mingarelli
CNC. De Nuccio
C. De Nuccio
SVSergio Visentin
Sergio Visentin
LMLuisa Minghetti
Luisa Minghetti

30 July 2010 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
RSRoberta De De Simone
Roberta De De Simone
CNCristina Elena Niturad
Cristina Elena Niturad
CNC. De Nuccio
C. De Nuccio
MAMaria Antonietta Ajmone‐Cat
Maria Antonietta Ajmone‐Cat
SVSergio Visentin
Sergio Visentin
LMLuisa Minghetti
Luisa Minghetti

7 September 1999 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
SVSergio Visentin
Sergio Visentin
MRMassimiliano Renzi
Massimiliano Renzi
CFClaudio Frank
Claudio Frank
AGAnita Greco
Anita Greco
GLGiulio Levi
Giulio Levi
1. Our aim was to assess whether ATP-induced inward currents in microglia are due to a single or more than one purinergic receptor. The ATP dose-response curve showed two components, whose presence might be due to the activation of high and low affinity receptors. 2. The P2Z/P2X7 specific receptor agonist benzoylbenzoyl-ATP (Bz-ATP) and some P2 receptor agonists were tested. The rank order of potency was Bz-ATP >> ATP = 2-methylthio-ATP (2-MeSATP) > alpha, beta-methylene ATP (alpha,beta-meATP) >= ADP. beta, gamma-MethyleneATP (beta,gamma-meATP), UTP and adenosine were ineffective. 3. The non-specific P2 receptor antagonist suramin antagonized by 92 +/- 2 % the inward current induced by 100 microM ATP, and by 51 +/- 8 and 68 +/- 6 % those induced by 3 mM ATP and 100 microM Bz-ATP, respectively. The P2Z/P2X7 antagonist oxidized ATP (oATP) almost abolished the inward current induced by 3 mM ATP or Bz-ATP, but was ineffective against 100 microM ATP. 4. Inward currents induced by low ATP concentrations (<= 100 microM) were generally followed by an almost complete and irreversible desensitization, while those elicited by ATP >= 1 mM showed only a partial decline. Interestingly, the inward current induced by 100 microM 2-MeSATP showed a large desensitization, while that induced by Bz-ATP did not. 5. In voltage-ramp experiments, the 100 microM ATP-induced current exhibited a slight inward rectification more visible at negative potentials, while the 3 mM ATP-induced current did not. 6. ATP induced a fast and large increase in [Ca2+] that promptly recovered in the continuous presence of low ATP doses, but did not recover in high ATP doses. As with desensitization, the response to Bz-ATP mimicked that of high doses of ATP. 7. When Ca2+ mobilization due to P2Y receptors was blocked by thapsigargin-induced Ca2+ depletion or by pertussis toxin treatment, 10 microM ATP was still able to induce a Ca2+ transient, which represented the contribution of the Ca2+ influx induced by P2X receptors 8. In conclusion, the inward currents and a fraction of the Ca2+ transients induced by ATP in microglia are due to at least two ATP-sensitive receptor channel types, whose different properties and sensitivity to ATP may be associated with different functional roles.

1 October 2011 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
CNC. De Nuccio
C. De Nuccio
ABAntonietta Bernardo
Antonietta Bernardo
RSRoberta De De Simone
Roberta De De Simone
EMEnrico Mancuso
Enrico Mancuso
Valerio MagnaghiValerio Magnaghi
Valerio Magnaghi
LMLuisa Minghetti
Luisa Minghetti
We have previously shown that natural (15-deoxy-Δ12,14-prostaglandin J2) and synthetic (pioglitazone) agonists of peroxisome proliferator-activated receptor γ (PPAR-γ) strengthen the intrinsic cellular mechanisms protecting oligodendrocyte (OL) progenitors (OPs) from oxidative insults and promote their differentiation. Here, we demonstrate that repeated administrations of PPAR-γ agonists to OP cultures accelerate their differentiation to OLs, as indicated by increased numbers of O4- and O1-positive cells that show increased myelin basic protein expression, elaborated cholesterol-enrichedmembranes and have increased peroxisomes. Moreover, PPAR-γ agonist-treated OLs show increased activity of the mitochondrial respiratory chain Complex IV and an increased ability to respond to environmental signals, such as adenosine diphosphate (ADP), with oscillatory Ca2+ waves; the latter closely correlated with the presence of mitochondria and were inhibited by the mitochondrial respiratory chain Complex I inhibitor rotenone. Because Ca2+ oscillations and mitochondrial respiratory chain activity play crucial roles in OL differentiation, these findings suggest that PPAR-γ agonists could protect OLs and promote myelination through several mechanisms, including those involving mitochondrial functions. Our studies support the therapeutic potential of PPAR-γ agonists in brain diseases in which mitochondrial alteration, oxidative stress, and demyelination occur and point to the need for a better understanding of the role of PPAR-γ and its agonists in OL biology.